APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sunitinib Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sunitinib Drug Market Analysis and Forecast 2026-2032

Report ID 174038680222 December 2025190 pages

Choose your research edition.

Industry ResearchSunitinib Drug Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Sunitinib Drug Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Sunitinib Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sunitinib Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sunitinib Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sunitinib Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Sunitinib Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sunitinib Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sunitinib Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sunitinib Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Sunitinib Drug include Pfizer. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Sunitinib Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sunitinib Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Sunitinib Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sunitinib Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sunitinib Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Sunitinib Drug revenue, projected growth trends, production technology, application and end-user industry.

Sunitinib Drug Segment by Company

Pfizer

Sunitinib Drug Segment by Type

50 mg Capsules

37.5 mg Capsules

25 mg Capsules

12.5 mg Capsules

Sunitinib Drug Segment by Application

pNET

GIST

Kidney cancer

Sunitinib Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sunitinib Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sunitinib Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sunitinib Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Sunitinib Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Sunitinib Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sunitinib Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sunitinib Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50 mg Capsules Major Player Table 3. 37.5 mg Capsules Major Player Table 4. 25 mg Capsules Major Player Table 5. 12.5 mg Capsules Major Player Table 6. Global Sunitinib Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. pNET Major Player Table 8. GIST Major Player Table 9. Kidney cancer Major Player Table 10. Sunitinib Drug Industry Trends Table 11. Sunitinib Drug Industry Drivers Table 12. Sunitinib Drug Industry Opportunities and Challenges Table 13. Sunitinib Drug Industry Restraints Table 14. Global Sunitinib Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Sunitinib Drug Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Sunitinib Drug Market Share by Region (2021-2026) Table 17. Global Sunitinib Drug Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Sunitinib Drug Market Share by Region (2027-2032) Table 19. Global Sunitinib Drug Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Sunitinib Drug Revenue Market Share by Players (2021-2026) Table 21. Global Sunitinib Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Sunitinib Drug Key Players Headquarters & Area Served Table 23. Global Sunitinib Drug Players, Product Type & Application Table 24. Global Sunitinib Drug Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Sunitinib Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Sunitinib Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Sunitinib Drug Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Sunitinib Drug Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Sunitinib Drug Revenue Market Share by Type (2021-2026) Table 31. Global Sunitinib Drug Revenue Market Share by Type (2027-2032) Table 32. Global Sunitinib Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Sunitinib Drug Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Sunitinib Drug Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Sunitinib Drug Revenue Market Share by Application (2021-2026) Table 36. Global Sunitinib Drug Revenue Market Share by Application (2027-2032) Table 37. Pfizer Company Information Table 38. Pfizer Business Overview Table 39. Pfizer Sunitinib Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Pfizer Sunitinib Drug Product Portfolio Table 41. Pfizer Recent Development Table 42. North America Sunitinib Drug Revenue by Type (2021-2026) & (US$ Million) Table 43. North America Sunitinib Drug Revenue by Type (2027-2032) & (US$ Million) Table 44. North America Sunitinib Drug Revenue by Application (2021-2026) & (US$ Million) Table 45. North America Sunitinib Drug Revenue by Application (2027-2032) & (US$ Million) Table 46. North America Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 47. North America Sunitinib Drug Revenue by Country (2021-2026) & (US$ Million) Table 48. North America Sunitinib Drug Revenue by Country (US$ Million) & (2027-2032) Table 49. Europe Sunitinib Drug Revenue by Type (2021-2026) & (US$ Million) Table 50. Europe Sunitinib Drug Revenue by Type (2027-2032) & (US$ Million) Table 51. Europe Sunitinib Drug Revenue by Application (2021-2026) & (US$ Million) Table 52. Europe Sunitinib Drug Revenue by Application (2027-2032) & (US$ Million) Table 53. Europe Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Europe Sunitinib Drug Revenue by Country (2021-2026) & (US$ Million) Table 55. Europe Sunitinib Drug Revenue by Country (US$ Million) & (2027-2032) Table 56. China Sunitinib Drug Revenue by Type (2021-2026) & (US$ Million) Table 57. China Sunitinib Drug Revenue by Type (2027-2032) & (US$ Million) Table 58. China Sunitinib Drug Revenue by Application (2021-2026) & (US$ Million) Table 59. China Sunitinib Drug Revenue by Application (2027-2032) & (US$ Million) Table 60. Asia Sunitinib Drug Revenue by Type (2021-2026) & (US$ Million) Table 61. Asia Sunitinib Drug Revenue by Type (2027-2032) & (US$ Million) Table 62. Asia Sunitinib Drug Revenue by Application (2021-2026) & (US$ Million) Table 63. Asia Sunitinib Drug Revenue by Application (2027-2032) & (US$ Million) Table 64. Asia Sunitinib Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 65. Asia Sunitinib Drug Revenue by Region (US$ Million) & (2021-2026) Table 66. Asia Sunitinib Drug Revenue by Region (US$ Million) & (2027-2032) Table 67. SAMEA Sunitinib Drug Revenue by Type (2021-2026) & (US$ Million) Table 68. SAMEA Sunitinib Drug Revenue by Type (2027-2032) & (US$ Million) Table 69. SAMEA Sunitinib Drug Revenue by Application (2021-2026) & (US$ Million) Table 70. SAMEA Sunitinib Drug Revenue by Application (2027-2032) & (US$ Million) Table 71. SAMEA Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. SAMEA Sunitinib Drug Revenue by Country (2021-2026) & (US$ Million) Table 73. SAMEA Sunitinib Drug Revenue by Country (US$ Million) & (2027-2032) Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Sunitinib Drug Image Figure 2. Global Sunitinib Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sunitinib Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50 mg Capsules Image Figure 5. 37.5 mg Capsules Image Figure 6. 25 mg Capsules Image Figure 7. 12.5 mg Capsules Image Figure 8. Global Sunitinib Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Sunitinib Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. pNET Image Figure 11. GIST Image Figure 12. Kidney cancer Image Figure 13. Global Sunitinib Drug Market Size (US$ Million) & (2021-2032) Figure 14. Global Sunitinib Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Sunitinib Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Sunitinib Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Sunitinib Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Sunitinib Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Sunitinib Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Sunitinib Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Sunitinib Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Sunitinib Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Sunitinib Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Sunitinib Drug Revenue Share by Type (2021-2032) Figure 26. North America Sunitinib Drug Revenue Share by Application (2021-2032) Figure 27. North America Sunitinib Drug Revenue Share by Country (2021-2032) Figure 28. United States Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Sunitinib Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Sunitinib Drug Revenue Share by Type (2021-2032) Figure 33. Europe Sunitinib Drug Revenue Share by Application (2021-2032) Figure 34. Europe Sunitinib Drug Revenue Share by Country (2021-2032) Figure 35. Germany Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Sunitinib Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Sunitinib Drug Revenue Share by Type (2021-2032) Figure 45. China Sunitinib Drug Revenue Share by Application (2021-2032) Figure 46. Asia Sunitinib Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Sunitinib Drug Revenue Share by Type (2021-2032) Figure 48. Asia Sunitinib Drug Revenue Share by Application (2021-2032) Figure 49. Asia Sunitinib Drug Revenue Share by Region (2021-2032) Figure 50. Japan Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Sunitinib Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Sunitinib Drug Revenue Share by Type (2021-2032) Figure 58. SAMEA Sunitinib Drug Revenue Share by Application (2021-2032) Figure 59. SAMEA Sunitinib Drug Revenue Share by Country (2021-2032) Figure 60. Brazil Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Sunitinib Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Capsules
  • 37.5 mg Capsules
  • 25 mg Capsules
  • 12.5 mg Capsules
Applications
  • pNET
  • GIST
  • Kidney cancer
Companies covered
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sunitinib Drug Market by Type
  3. 1.2.1 Global Sunitinib Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50 mg Capsules
  5. 1.2.3 37.5 mg Capsules
  6. 1.2.4 25 mg Capsules
  7. 1.2.5 12.5 mg Capsules
  8. 1.3 Sunitinib Drug Market by Application
  9. 1.3.1 Global Sunitinib Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 pNET
  11. 1.3.3 GIST
  12. 1.3.4 Kidney cancer
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Sunitinib Drug Market Dynamics
  1. 2.1 Sunitinib Drug Industry Trends
  2. 2.2 Sunitinib Drug Industry Drivers
  3. 2.3 Sunitinib Drug Industry Opportunities and Challenges
  4. 2.4 Sunitinib Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Sunitinib Drug Market Perspective (2021-2032)
  2. 3.2 Global Sunitinib Drug Growth Trends by Region
  3. 3.2.1 Global Sunitinib Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sunitinib Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Sunitinib Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Sunitinib Drug Revenue by Players
  2. 4.1.1 Global Sunitinib Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Sunitinib Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Sunitinib Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sunitinib Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Sunitinib Drug Key Players Headquarters & Area Served
  7. 4.4 Global Sunitinib Drug Players, Product Type & Application
  8. 4.5 Global Sunitinib Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Sunitinib Drug Market CR5 and HHI
  11. 4.6.3 2025 Sunitinib Drug Tier 1, Tier 2, and Tier 3
5 Sunitinib Drug Market Size by Type
  1. 5.1 Global Sunitinib Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Sunitinib Drug Revenue by Type (2021-2032)
  3. 5.3 Global Sunitinib Drug Revenue Market Share by Type (2021-2032)
6 Sunitinib Drug Market Size by Application
  1. 6.1 Global Sunitinib Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Sunitinib Drug Revenue by Application (2021-2032)
  3. 6.3 Global Sunitinib Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Sunitinib Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Sunitinib Drug Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Sunitinib Drug Revenue (2021-2032)
  2. 8.2 North America Sunitinib Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Sunitinib Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Sunitinib Drug Revenue by Type (2027-2032)
  5. 8.3 North America Sunitinib Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Sunitinib Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Sunitinib Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Sunitinib Drug Revenue by Application (2027-2032)
  9. 8.5 North America Sunitinib Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Sunitinib Drug Revenue by Country
  11. 8.6.1 North America Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Sunitinib Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Sunitinib Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Sunitinib Drug Revenue (2021-2032)
  2. 9.2 Europe Sunitinib Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Sunitinib Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Sunitinib Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Sunitinib Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Sunitinib Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Sunitinib Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Sunitinib Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Sunitinib Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Sunitinib Drug Revenue by Country
  11. 9.6.1 Europe Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Sunitinib Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Sunitinib Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Sunitinib Drug Revenue (2021-2032)
  2. 10.2 China Sunitinib Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Sunitinib Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Sunitinib Drug Revenue by Type (2027-2032)
  5. 10.3 China Sunitinib Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Sunitinib Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Sunitinib Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Sunitinib Drug Revenue by Application (2027-2032)
  9. 10.5 China Sunitinib Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sunitinib Drug Revenue (2021-2032)
  2. 11.2 Asia Sunitinib Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Sunitinib Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Sunitinib Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Sunitinib Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Sunitinib Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Sunitinib Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Sunitinib Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Sunitinib Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Sunitinib Drug Revenue by Country
  11. 11.6.1 Asia Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Sunitinib Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Sunitinib Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sunitinib Drug Revenue (2021-2032)
  2. 12.2 SAMEA Sunitinib Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Sunitinib Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Sunitinib Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Sunitinib Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Sunitinib Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Sunitinib Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Sunitinib Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Sunitinib Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Sunitinib Drug Revenue by Country
  11. 12.6.1 SAMEA Sunitinib Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Sunitinib Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Sunitinib Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst